HuGE Literature Finder
|
||
Records 1-100
|
Analysis of polymorphisms in genes associated with the FA/BRCA pathway in three patients with multiple primary malignant neoplasms.
Artificial cells, nanomedicine, and biotechnology 2019 Dec 47 (1): 1101-1112. Wang Le, Wang Hao, Wang Ting, Liu Jinhui, Chen Wei, Wang Yamin, Chen Chao, Zhu Hongli, Dai Pengg |
|
Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers.
Cancer 2019 Oct . Song Yun, Barry William T, Seah Davinia S, Tung Nadine M, Garber Judy E, Lin Nancy |
|
Family history is significantly associated with prostate cancer and its early onset in Chinese population.
The Prostate 2019 Sep . Xu Yang, Huang Da, Wu Yishuo, Ye Dingwei, Zhang Ning, Gao Yi, Xu Danfeng, Na Rong, Xu Jianfe |
|
Homologous recombination in lung cancer, germline and somatic mutations, clinical and phenotype characterization.
Lung cancer (Amsterdam, Netherlands) 2019 Sep 137 48-51. Kadouri Luna, Rottenberg Yakir, Zick Aviad, Hamburger Tamar, Lipson Doron, Peretz Tamar, Nechushtan Hov |
|
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.
European urology 2019 Sep . Page Elizabeth C, Bancroft Elizabeth K, Brook Mark N, Assel Melissa, Hassan Al Battat Mona, Thomas Sarah, Taylor Natalie, Chamberlain Anthony, Pope Jennifer, Raghallaigh Holly Ni, Evans D Gareth, Rothwell Jeanette, Mahle Lovise, Grindedal Eli Marie M, James Paul, Mascarenhas Lyon, McKinley Joanne, Side Lucy, Thomas Tessy, van Asperen Christi, Vasen Hans, Kiemeney Lambertus A, Ringelberg Janneke, Jensen Thomas Dyrsø, Osther Palle J S, Helfand Brian T, Genova Elena, Oldenburg Rogier A, Cybulski Cezary, Wokolorczyk Dominika, Ong Kai-Ren, Huber Camilla, Lam Jimmy, Taylor Louise, Salinas Monica, Feliubadaló Lidia, Oosterwijk Jan C, van Zelst-Stams Wendy, Cook Jackie, Rosario Derek J, Domchek Susan, Powers Jacquelyn, Buys Saundra, O'Toole Karen, Ausems Margreet G E M, Schmutzler Rita K, Rhiem Kerstin, Izatt Louise, Tripathi Vishakha, Teixeira Manuel R, Cardoso Marta, Foulkes William D, Aprikian Armen, van Randeraad Heleen, Davidson Rosemarie, Longmuir Mark, Ruijs Mariëlle W G, Helderman van den Enden Apollonia T J M, Adank Muriel, Williams Rachel, Andrews Lesley, Murphy Declan G, Halliday Dorothy, Walker Lisa, Liljegren Annelie, Carlsson Stefan, Azzabi Ashraf, Jobson Irene, Morton Catherine, Shackleton Kylie, Snape Katie, Hanson Helen, Harris Marion, Tischkowitz Marc, Taylor Amy, Kirk Judy, Susman Rachel, Chen-Shtoyerman Rakefet, Spigelman Allan, Pachter Nicholas, Ahmed Munaza, Ramon Y Cajal Teresa, Zgajnar Janez, Brewer Carole, Gadea Neus, Brady Angela F, van Os Theo, Gallagher David, Johannsson Oskar, Donaldson Alan, Barwell Julian, Nicolai Nicola, Friedman Eitan, Obeid Elias, Greenhalgh Lynn, Murthy Vedang, Copakova Lucia, Saya Sibel, McGrath John, Cooke Peter, Rønlund Karina, Richardson Kate, Henderson Alex, Teo Soo H, Arun Banu, Kast Karin, Dias Alexander, Aaronson Neil K, Ardern-Jones Audrey, Bangma Chris H, Castro Elena, Dearnaley David, Eccles Diana M, Tricker Karen, Eyfjord Jorunn, Falconer Alison, Foster Christopher, Gronberg Henrik, Hamdy Freddie C, Stefansdottir Vigdis, Khoo Vincent, Lindeman Geoffrey J, Lubinski Jan, Axcrona Karol, Mikropoulos Christos, Mitra Anita, Moynihan Clare, Rennert Gadi, Suri Mohnish, Wilson Penny, Dudderidge Tim, , Offman Judith, Kote-Jarai Zsofia, Vickers Andrew, Lilja Hans, Eeles Rosalind |
|
Prevalence and founder effect of the BRCA1 p.(Val1833Met) variant in the Greek population, with further evidence for pathogenicity and risk modification.
Cancer genetics 2019 Sep 237 90-96. Papamentzelopoulou Myrto, Apostolou Paraskevi, Fostira Florentia, Dimitrakakis Constantine, Loutradis Dimitris, Fountzilas George, Yannoukakos Drakoulis, Konstantopoulou Ire |
|
Exposure-response analysis to inform the optimal dose of veliparib in combination with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer patients.
Cancer chemotherapy and pharmacology 2019 Aug . Nuthalapati Silpa, Stodtmann Sven, Shepherd Stacie Peacock, Ratajczak Christine K, Mensing Sven, Menon Rajeev, Xiong H |
|
Germline and somatic mutations of multi-gene panel in Chinese patients with epithelial ovarian cancer: a prospective cohort study.
Journal of ovarian research 2019 Aug 12 (1): 80. Li Wenhui, Shao Di, Li Lei, Wu Ming, Ma Shuiqing, Tan Xianjie, Zhong Sen, Guo Fengming, Wang Zhe, Ye Mingz |
|
Prevalence of genetic susceptibility for breast and ovarian cancer in a non-cancer related study population: secondary germline findings from a Swiss single centre cohort.
Swiss medical weekly 2019 Aug 149 w20092. Kraemer Dennis, Azzarello-Burri Silvia, Steindl Katharina, Boonsawat Paranchai, Zweier Markus, Dedes Konstantin J, Joset Pascal, Fink Daniel, Rauch Ani |
|
Use of Mammographic Measurements to Predict Complications After Nipple-Sparing Mastectomy in BRCA Mutation Carriers.
Annals of surgical oncology 2019 Aug . Park Ko Un, Weiss Anna, Rosso Kelly, Yi Min, Hunt Kelly, Kuerer Henry, Hanson Summer E, Candelaria Rosalind, Tevis Sarah, Thompson Alasta |
|
Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case-control study.
BMC cancer 2019 Jul 19 (1): 722. Zayas-Villanueva Omar Alejandro, Campos-Acevedo Luis Daniel, Lugo-Trampe José de Jesús, Hernández-Barajas David, González-Guerrero Juan Francisco, Noriega-Iriondo María Fernanda, Ramírez-Sánchez Ilse Alejandra, Martínez-de-Villarreal Laura El |
|
Association of Cytokeratin 5 and Claudin 3 expression with BRCA1 and BRCA2 germline mutations in women with early breast cancer.
BMC cancer 2019 Jul 19 (1): 695. Danzinger Sabine, Tan Yen Yen, Rudas Margaretha, Kastner Marie-Theres, Weingartshofer Sigrid, Muhr Daniela, Singer Christian |
|
Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men.
European urology oncology 2019 Jul . Chandrasekar Thenappan, Gross Laura, Gomella Leonard G, Hegarty Sarah E, Leong Joon Yau, Giri Veda |
|
Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers.
Breast cancer research and treatment 2019 Jul . Heemskerk-Gerritsen Bernadette A M, Jager Agnes, Koppert Linetta B, Obdeijn A Inge-Marie, Collée Margriet, Meijers-Heijboer Hanne E J, Jenner Denise J, Oldenburg Hester S A, van Engelen Klaartje, de Vries Jakob, van Asperen Christi J, Devilee Peter, Blok Marinus J, Kets C Marleen, Ausems Margreet G E M, Seynaeve Caroline, Rookus Matti A, Hooning Maartje |
|
The yield of full BRCA1/2 genotyping in Israeli Arab high-risk breast/ovarian cancer patients.
Breast cancer research and treatment 2019 Jul . Bernstein-Molho Rinat, Barnes-Kedar Inbal, Ludman Mark D, Reznik Gili, Feldman Hagit Baris, Samra Nadra Nasser, Eilat Avital, Peretz Tamar, Peretz Lilach Peled, Shapira Tamar, Magal Nurit, Kalis Marina Lifshitc, Yerushalmi Rinat, Vinkler Chana, Liberman Sari, Basel-Salmon Lina, Shohat Mordechai, Levy-Lahad Ephrat, Friedman Eitan, Bazak Lily, Goldberg Ya |
|
BRCA mutation characteristics in a series of index cases of breast cancer selected independent of family history.
The breast journal 2019 Jun . Bisgin Atil, Boga Ibrahim, Yalav Orcun, Sonmezler Ozge, Tug Bozdogan Sevc |
|
Insights into BRCA Cancer Predisposition from Integrated Germline and Somatic Analyses in 7632 Cancers.
JNCI cancer spectrum 2019 Jun 3 (2): pkz028. Yost Shawn, Ruark Elise, Alexandrov Ludmil B, Rahman Nazne |
|
Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
Cancer 2019 Jun . Weitzel Jeffrey N, Neuhausen Susan L, Adamson Aaron, Tao Shu, Ricker Charité, Maoz Asaf, Rosenblatt Margalit, Nehoray Bita, Sand Sharon, Steele Linda, Unzeitig Gary, Feldman Nancy, Blanco Amie M, Hu Donglei, Huntsman Scott, Castillo Danielle, Haiman Christopher, Slavin Thomas, Ziv El |
|
The Spectrum of Mutations Predisposing to Familial Breast Cancer in Poland.
International journal of cancer 2019 Jun . Cybulski Cezary, Kluzniak Wojciech, Huzarski Tomasz, Wokolorczyk Dominika, Kashyap Aniruddh, Rusak Bogna, Stempa Klaudia, Gronwald Jacek, Szymiczek Agata, Bagherzadeh Maryam, Jakubowska Anna, Debniak Tadeusz, Lener Marcin, Rudnicka Helena, Szwiec Marek, Jarkiewicz-Tretyn Joanna, Stawicka Malgorzata, Domagala Pawel, Narod Steven A, Lubinski Jan, Akbari Mohammad R, |
|
Aspirin Treatment Effect and Association with PIK3CA Mutation in Breast Cancer: A Biomarker Analysis.
Clinical breast cancer 2019 May . Zhou Yunyun, Simmons Josh, Jordan Christina D, Sonbol Mohamad Bassam, Maihle Nita, Tang Shou-Chi |
|
Assessment of PARP4 as a candidate breast cancer susceptibility gene.
Breast cancer research and treatment 2019 May . Prawira Aldo, Munusamy Prabhakaran, Yuan Jimin, Chan Claire Hian Tzer, Koh Geok Ling, Shuen Timothy Wai Ho, Hu Jiancheng, Yap Yoon Sim, Tan Min Han, Ang Peter, Lee Ann Siew G |
|
Breast cancer risk associated with BRCA1/2 variants in the Pakistani population.
Breast cancer (Tokyo, Japan) 2019 May 26 (3): 365-372. Abbas Saba, Siddique Ayesha, Shahid Naeem, Khan Rabbia Tariq, Fatima War |
|
Bridging Olaparib Capsule and Tablet Formulations Using Population Pharmacokinetic Meta-analysis in Oncology Patients.
Clinical pharmacokinetics 2019 May 58 (5): 615-625. Zhou Diansong, Li Jianguo, Bui Khanh, Learoyd Maria, Berges Alienor, Milenkova Tsveta, Al-Huniti Nidal, Tomkinson Helen, Xu Hongm |
|
Clinical background and outcomes of risk-reducing salpingo-oophorectomy for hereditary breast and ovarian cancers in Japan.
International journal of clinical oncology 2019 May . Nomura Hidetaka, Sekine Masayuki, Yokoyama Shiro, Arai Masami, Enomoto Takayuki, Takeshima Nobuhiro, Nakamura Sei |
|
Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer.
Journal of ovarian research 2019 May 12 (1): 40. Kim Se Ik, Lee Maria, Kim Hee Seung, Chung Hyun Hoon, Kim Jae-Weon, Park Noh Hyun, Song Yong-Sa |
|
Genomic profiling in ovarian cancer retreated with platinum based chemotherapy presented homologous recombination deficiency and copy number imbalances of CCNE1 and RB1 genes.
BMC cancer 2019 May 19 (1): 422. da Costa Alexandre A B A, do Canto Luisa M, Larsen Simon Jonas, Ribeiro Adriana Regina Gonçalves, Stecca Carlos Eduardo, Petersen Annabeth Høgh, Aagaard Mads M, de Brot Louise, Baumbach Jan, Baiocchi Glauco, Achatz Maria Isabel, Rogatto Silvia Regi |
|
Is BRCA mutational status a predictor of platinum-based chemotherapy related hematologic toxicity in high-grade serous ovarian cancer patients?
Gynecologic oncology 2019 May . Tomao Federica, Musacchio Lucia, Di Mauro Federica, Boccia Serena Maria, Di Donato Violante, Giancotti Antonella, Perniola Giorgia, Palaia Innocenza, Muzii Ludovico, Benedetti Panici Pierlui |
|
Multigene panel testing in unselected Israeli breast cancer cases: mutational spectrum and use of BRCA1/2 mutation prediction algorithms.
Breast cancer research and treatment 2019 Apr . Bernstein-Molho Rinat, Singer Amihood, Laitman Yael, Netzer Iris, Zalmanoviz Shelley, Friedman Eit |
|
Association between family history, mutation locations, and prevalence of BRCA1 or 2 mutations in ovarian cancer patients.
Cancer medicine 2019 Mar . Singer Christian F, Tan Yen Y, Muhr Daniela, Rappaport Christine, Gschwantler-Kaulich Daphne, Grimm Christoph, Polterauer Stephan, Pfeiler Georg, Berger Andreas, Tea Muy-Kheng |
|
Exploring genetic counselors' perceptions of usefulness and intentions to use refined risk models in clinical care based on the Technology Acceptance Model (TAM).
Journal of genetic counseling 2019 Mar . Heinlen Christopher, Hovick Shelly R, Brock Guy N, Klamer Brett G, Toland Amanda Ewart, Senter Leig |
|
Novel Associations between BRCA1 Variants C.181 T>G (Rs28897672) and Ovarian Crisk in Saudi Females.
Journal of medical biochemistry 2019 Mar 38 (1): 13-21. Alyahri Nora, Abdi Saba, Khan Wajahatullah, Elrobh Mohamed, Addar Mohammed H, Babay Zeneb A, Alanazi Mohamed, Aldaihan Sooad, Shaik Jilani, Arafah Maha, Parine Narasimha Reddy, Warsy Arjuma |
|
Opportunistic testing of BRCA1, BRCA2 and mismatch repair genes improves the yield of phenotype driven hereditary cancer gene panels.
International journal of cancer 2019 Mar . Feliubadaló Lídia, López-Fernández Adrià, Pineda Marta, Díez Orland, Del Valle Jesús, Gutiérrez-Enríquez Sara, Teulé Alex, González Sara, Stjepanovic Neda, Salinas Mónica, Capellá Gabriel, Brunet Joan, Lázaro Conxi, Balmaña Judith, |
|
Prevalence of BRCA mutations among hereditary breast and/or ovarian cancer patients in Arab countries: systematic review and meta-analysis.
BMC cancer 2019 Mar 19 (1): 256. Abdulrashid Khadiga, AlHussaini Nour, Ahmed Wifag, Thalib Lukm |
|
Prevalence, spectrum and founder effect of BRCA1 and BRCA2 mutations in Epithelial Ovarian Cancer from Middle East.
Human mutation 2019 Mar . Siraj Abdul K, Bu Rong, Iqbal Kaleem, Siraj Nabil, Al-Haqawi Wael, Al-Badawi Ismail A, Parvathareddy Sandeep Kumar, Masoodi Tariq, Tulbah Asma, Al-Dayel Fouad, Al-Kuraya Khawla |
|
The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysis.
The Prostate 2019 Mar . Oh Mok, Alkhushaym Nasser, Fallatah Saad, Althaghfi Abdulhamid, Aljadeed Rana, Alsowaida Yazed, Jeter Joanne, Martin Jennifer R, Babiker Hani M, McBride Ali, Abraham I |
|
Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers.
Cancer 2019 Mar 125 (5): 698-703. Laitman Yael, Michaelson-Cohen Rachel, Levi Einat, Chen-Shtoyerman Rakefet, Reish Orit, Josefsberg Ben-Yehoshua Sagi, Bernstein-Molho Rinat, Keinan-Boker Lital, Rosengarten Ora, Silverman Barbara G, Perri Tamar, Korach Jacob, Mor Pnina, Ephrat Ben-Baruch Noa, Levy Lahad Ephrat, Friedman Eitan, |
|
Oncology letters 2019 Feb 17 (2): 1986-1995. Huszno Joanna, Kolosza Zofia, Grzybowska E |
|
BRCA gene mutations do not shape the extent and organization of tumor infiltrating lymphocytes in triple negative breast cancer.
Cancer letters 2019 Feb . Solinas Cinzia, Marcoux Diane, Garaud Soizic, Vitória Joel Rodrigues, Van den Eynden Gert, de Wind Alexandre, De Silva Pushpamali, Boisson Anais, Craciun Ligia, Larsimont Denis, Piccart-Gebhart Martine, Detours Vincent, Roodenbeke Daphné t'Kint de, Willard-Gallo Kar |
|
BRCA1 and BRCA2 Germline Mutation Analysis in Hereditary Breast/Ovarian Cancer Families from the Aures Region (Eastern Algeria): First Report.
Pathology oncology research : POR 2019 Feb . Mehemmai Chiraz, Cherbal Farid, Hamdi Yosr, Guedioura Abdelmoumene, Benbrahim Wassila, Bakour Rabah, Abdelhak Son |
|
Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers.
Breast cancer research and treatment 2019 Feb . Kotsopoulos Joanne, Lubinski Jan, Lynch Henry T, Tung Nadine, Armel Susan, Senter Leigha, Singer Christian F, Fruscio Robert, Couch Fergus, Weitzel Jeffrey N, Karlan Beth, Foulkes William D, Moller Pal, Eisen Andrea, Ainsworth Peter, Neuhausen Susan L, Olopade Olufunmilayo, Sun Ping, Gronwald Jacek, Narod Steven A, |
|
Revealing clonality and subclonality of driver genes for clinical survival benefits in breast cancer.
Breast cancer research and treatment 2019 Feb . Lan Yujia, Zhao Erjie, Luo Shangyi, Xiao Yun, Li Xia, Cheng Shuj |
|
BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
Molecular genetics & genomic medicine 2019 Jan . Liu Yan, Ide Yoshimi, Inuzuka Mayuko, Tazawa Sakiko, Kanada Yoko, Matsunaga Yuki, Kuwayama Takashi, Sawada Terumasa, Akashi-Tanaka Sadako, Nakamura Sei |
|
Differences between screen-detected and interval breast cancers among BRCA mutation carriers.
Breast cancer research and treatment 2019 Jan . Pilewskie Melissa, Zabor Emily C, Gilbert Elizabeth, Stempel Michelle, Petruolo Oriana, Mangino Debra, Robson Mark, Jochelson Maxine |
|
Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study.
Human genomics 2019 Jan 13 (1): 4. Yi Dandan, Xu Lei, Luo Jiaqi, You Xiaobin, Huang Tao, Zi Yi, Li Xiaoting, Wang Ru, Zhong Zaixuan, Tang Xiaoqiao, Li Ang, Shi Yujian, Rao Jianmei, Zhang Yifen, Sang Jianfe |
|
Germline variation in BRCA1/2 is highly ethnic-specific: evidence from over 30,000 Chinese hereditary breast and ovarian cancer patients.
International journal of cancer 2019 Jan . Bhaskaran Shanmuga Priya, Chandratre Khyati, Gupta Hemant, Zhang Li, Wang Xiaoyu, Cui Jian, Kim Yeong C, Sinha Siddharth, Jiang Luhan, Lu Boya, Wu Xiaobing, Qin Zixin, Huang Teng, Wang San Mi |
|
Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea.
Breast cancer research and treatment 2019 Jan 173 (2): 385-395. Ryu Jai Min, Choi Hee Jun, Kim Isaac, Nam Seok Jin, Kim Seok Won, Yu Jonghan, Lee Se Kyung, Choi Doo Ho, Park Yeon Hee, Kim Jong-Won, Seo Jeong-Sun, Park Jung-Hoon, Lee Jeong Eon, Kim Sung-Won, |
|
Contribution of Massive Parallel Sequencing to Diagnosis of Hereditary Ovarian Cancer in the Czech Republic.
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2019 32 (Supplementum2): 72-78. Soukupová Jana, Lhotová Klára, Zemánková Petra, Vocka Michal, Janatová Markéta, Stolarová Lenka, Borecká Marianna, Kleiblová Petra, Machácková Eva, Foretová Lenka, Koudová Monika, Lhota Filip, Tavandzis Spiros, Zikán Michal, Stránecký Viktor, Veselá Kamila, Panczak Aleš, Kotlas Jaroslav, Kleibl Zden |
|
Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot Study.
Genes 2019 09 10 (9): . Dugo Matteo, Devecchi Andrea, De Cecco Loris, Cecchin Erika, Mezzanzanica Delia, Sensi Marialuisa, Bagnoli Mari |
|
Molecular and immunohistochemical analyses of uveal melanoma patient cohort.
Melanoma research 2019 06 29 (3): 248-253. Sarubi Helena C, Pereira Núbia B, Gomes Carolina C, Gomez Ricardo S, Carmo Ana C M, Melo Flavia M, Bastos-Rodrigues Luciana, Pedrosa Moisés S, Friedman Eitan, De Marco Lu |
|
Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: a case report.
BMC cancer 2018 Dec 18 (1): 1253. Lin Zhenyu, Liu Junli, Peng Li, Zhang Dejun, Jin Ming, Wang Jing, Xue Jun, Liu Hongli, Zhang T |
|
Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A meta-analysis.
Critical reviews in oncology/hematology 2018 Dec 132 111-115. Marchetti C, De Felice F, Boccia S, Sassu C, Di Donato V, Perniola G, Palaia I, Monti M, Muzii L, Tombolini V, Benedetti Panici |
|
BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis.
Journal of the National Cancer Institute 2018 Nov 110 (11): 1178-1189. Oh Mok, McBride Ali, Yun Seongseok, Bhattacharjee Sandipan, Slack Marion, Martin Jennifer R, Jeter Joanne, Abraham I |
|
Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada.
BMC cancer 2018 Oct 18 (1): 1039. Arora Nimisha, Talhouk Aline, McAlpine Jessica N, Law Michael R, Hanley Gillian |
|
Clinical outcomes of adolescents and young adults with advanced solid tumours participating in phase I trials.
European journal of cancer (Oxford, England : 1990) 2018 Sep 101 55-61. Sundar Raghav, McVeigh Terri, Dolling David, Petruckevitch Ann, Diamantis Nikolaos, Ang Joo Ern, Chenard-Poiriér Maxime, Collins Dearbhaile, Lim Joline, Ameratunga Malaka, Khan Khurum, Kaye Stan B, Banerji Udai, Lopez Juanita, George Angela J, de Bono Johann S, van der Graaf Winette |
|
Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort.
International journal of cancer 2018 Sep . Li Jingmei, Wen Wei Xiong, Eklund Martin, Kvist Anders, Eriksson Mikael, Christensen Helene Nordahl, Torstensson Astrid, Bajalica-Lagercrantz Svetlana, Dunning Alison M, Decker Brennan, Allen Jamie, Luccarini Craig, Pooley Karen, Simard Jacques, Dorling Leila, Easton Douglas F, Teo Soo-Hwang, Hall Per, Borg Åke, Grönberg Henrik, Czene Kami |
|
Psychosocial Impact of BRCA Testing in Young Black Breast Cancer Survivors.
Psycho-oncology 2018 Sep . Gonzalez Brian D, Hoogland Aasha I, Kasting Monica L, Cragun Deborah, Kim Jongphil, Ashing Kimlin, Holt Cheryl L, Hughes Halbert Chanita, Pal Tuya, Vadaparampil Susan |
|
A portrait of germline mutation in Brazilian at-risk for hereditary breast cancer.
Breast cancer research and treatment 2018 Aug . de Souza Timoteo Ana Rafaela, Gonçalves Ana Élida Menezes Magalhães, Sales Lucas Amadeus Porpino, Albuquerque Betina Menezes, de Souza Jorge Estefano Santana, de Moura Patrícia Cristina Pascoto, de Aquino Marcos Alberto Arruda, Agnez-Lima Lucymara Fassarela, Lajus Tirzah Braz Pet |
|
Accuracy of Risk Prediction Models for Breast Cancer and BRCA1/BRCA2 Mutation Carrier Probabilities in Israel.
Anticancer research 2018 Aug 38 (8): 4557-4563. Kenan Efrat Schwarz, Friger Michael, Shochat-Bigon Daphna, Schayek Hagit, Bernstein-Molho Rinat, Friedman Eit |
|
Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing.
JAMA oncology 2018 Aug . Lu Hsiao-Mei, Li Shuwei, Black Mary Helen, Lee Shela, Hoiness Robert, Wu Sitao, Mu Wenbo, Huether Robert, Chen Jefferey, Sridhar Srijani, Tian Yuan, McFarland Rachel, Dolinsky Jill, Tippin Davis Brigette, Mexal Sharon, Dunlop Charles, Elliott Aar |
|
BRCA germline mutations in an unselected nationwide cohort of Chinese patients with ovarian cancer and healthy controls.
Gynecologic oncology 2018 Aug . Li Ang, Xie Rong, Zhi Qihuan, Deng Yixiao, Wu Yangming, Li Weiwei, Yang Lu, Jiao Zinan, Luo Jiaqi, Zi Yi, Sun Gang, Zhang Jiajia, Shi Yujian, Liu Ji |
|
BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients.
Breast cancer research and treatment 2018 Aug 171 (1): 85-94. Wunderle Marius, Gass Paul, Häberle Lothar, Flesch Vivien M, Rauh Claudia, Bani Mayada R, Hack Carolin C, Schrauder Michael G, Jud Sebastian M, Emons Julius, Erber Ramona, Ekici Arif B, Hoyer Juliane, Vasileiou Georgia, Kraus Cornelia, Reis Andre, Hartmann Arndt, Lux Michael P, Beckmann Matthias W, Fasching Peter A, Hein Alexand |
|
Prevalence of BRCA1 and BRCA2 Mutations Among High-Risk Saudi Patients With Breast Cancer.
Journal of global oncology 2018 Aug (4): 1-9. Abulkhair Omalkhair, Al Balwi Mohammed, Makram Ola, Alsubaie Lamia, Faris Medhat, Shehata Hussam, Hashim Ahmed, Arun Banu, Saadeddin Ahmed, Ibrahim Ezzeld |
|
Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations.
Breast cancer research and treatment 2018 Jul 170 (1): 101-109. Clifton Katherine, Gutierrez-Barrera Angelica, Ma Junsheng, Bassett Roland, Litton Jennifer, Kuerer Henry, Moulder Stacy, Albarracin Constance, Hortobagyi Gabriel, Arun Ba |
|
Benchmarking of Amplicon-Based Next-Generation Sequencing Panels Combined with Bioinformatics Solutions for Germline BRCA1 and BRCA2 Alteration Detection.
The Journal of molecular diagnostics : JMD 2018 Jul . Vendrell Julie A, Vilquin Paul, Larrieux Marion, Van Goethem Charles, Solassol Jérô |
|
BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management.
The breast journal 2018 Jul . Loi Mauro, Desideri Isacco, Olmetto Emanuela, Francolini Giulio, Greto Daniela, Bonomo Pierluigi, Simontacchi Gabriele, Di Brina Lucia, Meattini Icro, Livi Loren |
|
Clinicopathologic features and BRCA mutations in primary fallopian tube cancer in Japanese women.
Japanese journal of clinical oncology 2018 Jul . Sakurada Shoko, Watanabe Yoh, Tokunaga Hideki, Takahashi Fumiaki, Yamada Hidekazu, Takehara Kazuhiro, Yaegashi Nob |
|
Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2018 Jul 47 (5): 2088-2096. Shi Tingyan, Wang Pan, Tang Wenbin, Jiang Rong, Yin Sheng, Shi Di, Wang Qing, Wei Qingyi, Zang Rong |
|
Capillary electrophoresis as alternative method to detect tumor genetic mutations: the model built on the founder BRCA1 c.4964_4982del19 variant.
Familial cancer 2018 Jun . De Bonis Maria, Minucci Angelo, Scaglione Giovanni Luca, De Paolis Elisa, Zannoni Gianfranco, Scambia Giovanni, Capoluongo Etto |
|
Comparison of background parenchymal enhancement and fibroglandular density at breast magnetic resonance imaging between BRCA gene mutation carriers and non-carriers.
Clinical imaging 2018 Jun 51 347-351. Grubstein Ahuva, Rapson Yael, Benzaquen Oshra, Rozenblatt Shira, Gadiel Itay, Atar Eli, Yerushalmi Rinat, Cohen Matan |
|
Increased centrosome number in BRCA-related breast cancer specimens determined by immunofluorescence analysis.
Cancer science 2018 Jun 109 (6): 2027-2035. Watanabe Gou, Chiba Natsuko, Nomizu Tadashi, Furuta Akihiko, Sato Kaolu, Miyashita Minoru, Tada Hiroshi, Suzuki Akihiko, Ohuchi Noriaki, Ishida Takano |
|
Multicenter cross-sectional screening of the BRCA gene for Chinese high hereditary risk breast cancer populations.
Oncology letters 2018 Jun 15 (6): 9420-9428. Wei Hongyi, Wang Minghao, Ou Jianghua, Jiang Weihua, Tian Fuguo, Sheng Yuan, Li Hengyu, Xu Hong, Zhang Ruishan, Guan Aihua, Wang Changqing, Jiang Hongchuan, Ren Yu, He Jianjun, Liu Jian, Huang Weiwei, Liao Ning, Cai Xiangjun, Ming Jia, Ling Rui, Xu Yan, Hu Chunyan, Zhang Jianguo, Guo Baoliang, Ouyang Lizhi, Shuai Ping, Liu Zhenzhen, Zhong Ling, Jing Ruilin, Zeng Zhen, Zhang Meng, Zhang Ting, Xuan Zhaoling, Tan Xuanni, Liang Junbin, Pan Qinwen, Chen Li, Zhang Fan, Fan Linjun, Zhang Yi, Yang Xinhua, Li Jingbo, Chen Chongjian, Jiang J |
|
Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis.
Annals of oncology : official journal of the European Society for Medical Oncology 2018 Jun . Poggio F, Bruzzone M, Ceppi M, Pondé N F, La Valle G, Del Mastro L, de Azambuja E, Lambertini |
|
Subsequent breast and high grade serous carcinomas after risk-reducing salpingo-oophorectomy in BRCA mutation carriers and patients with history of breast cancer.
Annals of diagnostic pathology 2018 Jun 36 28-30. Straub Melissa M, Podoll Mirna B, David Stephanie N, Wiesner Georgia L, Desouki Mohamed |
|
BRCA1 Mutations Associated With Increased Risk of Brain Metastases in Breast Cancer: A 1: 2 Matched-pair Analysis.
American journal of clinical oncology 2018 May . Zavitsanos Peter J, Wazer David E, Hepel Jaroslaw T, Wang Yihong, Singh Kamaljeet, Leonard Kara |
|
Evaluation of tolerability and efficacy of incorporating carboplatin in neoadjuvant anthracycline and taxane based therapy in a BRCA1 enriched triple-negative breast cancer cohort.
Breast (Edinburgh, Scotland) 2018 May 40 141-146. Sella Tal, Gal Yam Einav Nili, Levanon Keren, Rotenberg Tal Shapira, Gadot Moran, Kuchuk Iryna, Molho Rinat Bernstein, Itai Amit, Modiano Tami Mekel, Gold Raya, Kaufman Bella, Shimon Shani Palu |
|
Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma.
Scientific reports 2018 May 8 (1): 8105. Takeuchi Shoko, Doi Manami, Ikari Naoki, Yamamoto Masakazu, Furukawa To |
|
Safety and pharmacokinetics of veliparib extended-release in patients with advanced solid tumors: a phase I study.
Cancer medicine 2018 May . Werner Theresa L, Sachdev Jasgit, Swisher Elizabeth M, Gutierrez Martin, Kittaneh Muaiad, Stein Mark N, Xiong Hao, Dunbar Martin, Sullivan Danielle, Komarnitsky Philip, McKee Mark, Tan Antoinette |
|
The role of PARP inhibition in triple-negative breast cancer: Unraveling the wide spectrum of synthetic lethality.
Cancer treatment reviews 2018 May 67 34-44. Papadimitriou Marios, Mountzios Giannis, Papadimitriou Christos |
|
BRCAmut and "founder effect": a prospective study in a single academic institution.
Oncotarget 2018 Apr 9 (32): 22353-22358. Loizzi Vera, Cicinelli Ettore, Santamaria Francesco, Murgia Ferdinando, Minicucci Valentina, Resta Leonardo, Resta Nicoletta, Natalicchio Maria Iole, Ranieri Girolamo, Cormio Genna |
|
Frequency of Rearrangements Versus Small Indels Mutations in BRCA1 and BRCA2 Genes in Turkish Patients with High Risk Breast and Ovarian Cancer.
European journal of breast health 2018 Apr 14 (2): 93-99. Yaz?c? Hülya, K?l?ç Seda, Akdeniz Demet, ?ükrüo?lu Özge, Tuncer ?eref Bu?ra, Av?ar Mukaddes, Kuru Gözde, Çelik Betül, Küçücük Seden, Saip P?n |
|
Pathology findings and clinical outcomes after risk reduction salpingo-oophorectomy in BRCA mutation carriers: a multicenter Spanish study.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2018 Apr . Minig L, Cabrera S, Oliver R, Couso A, Rubio M J, Iacoponi S, Martin-Salamanca M B, Carballo-Rastrilla S, Cádenas-Rebollo J M, García-Garcia A, Gil-Ibáñez B, Juan-Fita M J, Patrono M |
|
Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma.
Cancer 2018 Apr 124 (7): 1374-1382. O'Reilly Eileen M, Lee Jonathan W, Lowery Maeve A, Capanu Marinela, Stadler Zsofia K, Moore Malcolm J, Dhani Neesha, Kindler Hedy L, Estrella Hayley, Maynard Hannah, Golan Talia, Segal Amiel, Salo-Mullen Erin E, Yu Kenneth H, Epstein Andrew S, Segal Michal, Brenner Robin, Do Richard K, Chen Alice P, Tang Laura H, Kelsen David |
|
Somatic mutations in early onset luminal breast cancer.
Oncotarget 2018 Apr 9 (32): 22460-22479. Encinas Giselly, Sabelnykova Veronica Y, de Lyra Eduardo Carneiro, Hirata Katayama Maria Lucia, Maistro Simone, de Vasconcellos Valle Pedro Wilson Mompean, de Lima Pereira Gláucia Fernanda, Rodrigues Lívia Munhoz, de Menezes Pacheco Serio Pedro Adolpho, de Gouvêa Ana Carolina Ribeiro Chaves, Geyer Felipe Correa, Basso Ricardo Alves, Pasini Fátima Solange, Del Pilar Esteves Diz Maria, Brentani Maria Mitzi, Guedes Sampaio Góes João Carlos, Chammas Roger, Boutros Paul C, Koike Folgueira Maria Aparecida Azeve |
|
Germline breast cancer susceptibility gene mutations and breast cancer outcomes.
BMC cancer 2018 Mar 18 (1): 315. Wang Yong Alison, Jian Jhih-Wei, Hung Chen-Fang, Peng Hung-Pin, Yang Chi-Fan, Cheng Hung-Chun Skye, Yang An-Su |
|
Impact of BRCA mutations on outcomes among patients with serous endometrial cancer.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2018 Mar . Kadan Yfat, Raviv Oshrat, Segev Yakir, Lavie Ofer, Bruchim Ilan, Fishman Ami, Michaelson Rachel, Beller Uzi, Helpman Lim |
|
Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube.
Journal of gynecologic oncology 2018 Mar . Choi Min Chul, Bae Jin Sik, Jung Sang Geun, Park Hyun, Joo Won Duk, Song Seung Hun, Lee Chan, Kim Ji Ho, Lee Ki Chan, Lee Sunghoon, Lee Je |
|
Bone loss in women with BRCA1 and BRCA2 mutations.
Gynecologic oncology 2018 Feb . Powell C Bethan, Alabaster Amy, Stoller Nicole, Armstrong Mary Anne, Salyer Chelsea, Hamilton Isabella, Raine-Bennett Ti |
|
BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer.
Breast cancer research and treatment 2018 Feb 168 (1): 117-126. Nilsson Martin P, Törngren Therese, Henriksson Karin, Kristoffersson Ulf, Kvist Anders, Silfverberg Barbro, Borg Åke, Loman Nikl |
|
Difference in Risk of Breast and Ovarian Cancer According to Putative Functional Domain Regions in Korean BRCA1/2 Mutation Carriers.
Clinical breast cancer 2018 Feb . Park Ji Soo, Lee Seung-Tae, Han Jung Woo, Kim Tae Il, Nam Eun Ji, Park Hyung Se |
|
Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide.
European urology 2018 Feb . Antonarakis Emmanuel S, Lu Changxue, Luber Brandon, Liang Chao, Wang Hao, Chen Yan, Silberstein John L, Piana Danilo, Lai Zhao, Chen Yidong, Isaacs William B, Luo J |
|
Comprehensive BRCA mutation analysis in the Greek population. Experience from a single clinical diagnostic center.
Cancer genetics 2018 Jan 220 1-12. Apessos Angela, Agiannitopoulos Konstantinos, Pepe Georgia, Tsaousis Georgios N, Papadopoulou Eirini, Metaxa-Mariatou Vasiliki, Tsirigoti Angeliki, Efstathiadou Chrysoula, Markopoulos Christos, Xepapadakis Grigorios, Venizelos Vasileios, Tsiftsoglou Aris, Natsiopoulos Ioannis, Nasioulas Geor |
|
Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.
The Lancet. Oncology 2018 Jan . Copson Ellen R, Maishman Tom C, Tapper Will J, Cutress Ramsey I, Greville-Heygate Stephanie, Altman Douglas G, Eccles Bryony, Gerty Sue, Durcan Lorraine T, Jones Louise, Evans D Gareth, Thompson Alastair M, Pharoah Paul, Easton Douglas F, Dunning Alison M, Hanby Andrew, Lakhani Sunil, Eeles Ros, Gilbert Fiona J, Hamed Hisham, Hodgson Shirley, Simmonds Peter, Stanton Louise, Eccles Diana |
|
High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients.
Breast cancer research and treatment 2018 Jan . Alhuqail Al-Joharah, Alzahrani Areej, Almubarak Hannah, Al-Qadheeb Sarah, Alghofaili Lamyaa, Almoghrabi Nisreen, Alhussaini Hamed, Park Ben Ho, Colak Dilek, Karakas Bed |
|
Rapid detection of BRCA1/2 recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panels.
Oncotarget 2018 Jan 9 (8): 7832-7843. Kwong Ava, Ho John C W, Shin Vivian Y, Kurian Allison W, Tai Edmund, Esserman Laura J, Weitzel Jeffery N, Lin Po-Han, Field Michael, Domchek Susan M, Lo Jessica, Ngan Hextan Y S, Ma Edmond S K, Chan Tsun L, Ford James |
|
BRCA mutations in women with inflammatory breast cancer.
Cancer 2018 02 124 (3): 466-474. Gutierrez Barrera Angelica M, Fouad Tamer M, Song Juhee, Webster Rachel, Elsayegh Nisreen, Wood Anita L, Demir Atakan, Litton Jennifer K, Ueno Naoto T, Arun Banu |
|
BRCA1 deficiency is a recurrent event in early-onset triple-negative breast cancer: a comprehensive analysis of germline mutations and somatic promoter methylation.
Breast cancer research and treatment 2018 02 167 (3): 803-814. Brianese Rafael Canfield, Nakamura Kivvi Duarte de Mello, Almeida Fernanda Gabriella Dos Santos Ramos de, Ramalho Rodrigo Fernandes, Barros Bruna Durães de Figueiredo, Ferreira Elisa Napolitano E, Formiga Maria Nirvana da Cruz, de Andrade Victor Piana, de Lima Vladmir Claudio Cordeiro, Carraro Dirce Mar |
|
BRCA1/BRCA2 Germline Mutation Carriers and Sporadic Pancreatic Ductal Adenocarcinoma.
Journal of the American College of Surgeons 2018 04 226 (4): 630-637.e1. Blair Alex B, Groot Vincent P, Gemenetzis Georgios, Wei Jishu, Cameron John L, Weiss Matthew J, Goggins Michael, Wolfgang Christopher L, Yu Jun, He J |
|
Germline
Cancer management and research 2018 10 6505-6516. Mehta Anurag, Vasudevan Smreti, Sharma Sanjeev Kumar, Kumar Dushyant, Panigrahi Manoj, Suryavanshi Moushumi, Gupta Gari |
|
Platinum-based neoadjuvant chemotherapy in BRCA1-positive breast cancer: a retrospective cohort analysis and literature review.
Hereditary cancer in clinical practice 2018 16 9. Sæther Nikolai Havn, Skuja Elina, Irmejs Arvids, Maksimenko Jelena, Miklasevics Edvins, Purkalne Gunta, Gardovskis Jan |
|
The Use of Sentinel Lymph Node Biopsy in BRCA1/2 Mutation Carriers Undergoing Prophylactic Mastectomy: A Retrospective Consecutive Case-Series Study.
International journal of breast cancer 2018 2018 1426369. Câmara Sara, Pereira Daniela, André Saudade, Mira Beatriz, Vaz Fátima, Oom Rodrigo, Marques José Carlos, Leal de Faria João, Rodrigues Dos Santos Catari |
- Page last reviewed:Jul 30, 2019
- Page last updated:Oct 10, 2019
- Content source: